The six months study of unoprostone eye drop therapy for retinitis pigmentosa

Trial Profile

The six months study of unoprostone eye drop therapy for retinitis pigmentosa

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Unoprostone (Primary)
  • Indications Retinitis pigmentosa
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2014 New trial record
    • 23 Oct 2013 2-year results of this study have been presented at the International Society for Clinical Electrophysiology of Vision 2013, according to a R Tech Ueno media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top